South Korean retailer Lotte (KRX:004990) will acquire 2,555,804 common shares in its unit Lotte Biologics through its shareholder rights offering with an investment totalling 155.03 billion won, according to a Tuesday filing with the Korea Exchange.
The retailer said that the transaction is scheduled to close on Aug. 19, following which its cumulative investment in the affiliate will be 883.14 billion won, including the latest contribution.